Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Ding, W; LaPlant, BR; Call, TG; Parikh, SA; Leis, JF; He, R; Shanafelt, TD; Sinha, S; Le-Rademacher, J; Feldman, AL; Habermann, TM; Witzig, TE; Wiseman, GA; Lin, Y; Asmus, E; Nowakowski, GS; Conte, MJ; Bowen, DA; Aitken, CN; Van Dyke, DL; Greipp, PT;

Ding, W (reprint author), Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA.

BLOOD, 2017; 129 (26): 3419

Abstract

Chronic lymphocytic leukemia (CLL) patients progressed early on ibrutinib often develop Richter transformation (RT) with a short survival of about 4 m......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索